ILD drug development
See the following -
Interstitial Lung Disease (ILD) Experts And Advocates Announce Formation Of Open Source Imaging Consortium (OSIC)
Press Release |
Open Source Imaging Consortium (OSIC) |
May 22, 2019
An international group of leading experts and advocates in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases including emphysematous conditions announced today the formation of the Open Source Imaging Consortium (OSIC). This global, not-for-profit organization is a cooperative and open source effort between academia, industry and philanthropy to enable rapid advances in the detection and diagnosis of these conditions through digital imaging and machine learning.
- Login to post comments